Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation

Pharmacotherapy

Volumn 16, Issue 3 I, 1996, Pages 458-462

  Lindsay, Christine A ^a   Bawdon, Roger ^a   Quigley, Raymond ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAVULANIC ACID; TICARCILLIN; TIMENTIN;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CRITICAL ILLNESS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; EXTRACORPOREAL OXYGENATION; FEMALE; HEMOFILTRATION; HUMAN; MALE;

ADOLESCENT; CHILD; CLAVULANIC ACIDS; DRUG THERAPY, COMBINATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMOFILTRATION; HUMANS; MALE; TICARCILLIN;

EID: 0030013340     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Yorgin PD, Krensky AM, Tune BM. Continuous venovenous hemofiltration. Pediatr Nephrol 1990;4:640-2.
2. Zobel G, Ring E, Kuttnig M, Bruggauer HM. Five years' experience with continuous extracorporeal renal support in paediatric intensive care. Intensive Care Med 1991;17:315-19.
3. Ellis EN, Pearson D, Robinson L, Belsha CW, Wells TG, Berry PL. Pump-assisted hemofiltration in infants with acute renal failure. Pediatr Nephrol 1993;7:434-7.
4. Bunchman TE, Donckerwolcke RA. Continuous arterial-venous diahemofiltration and continuous veno-venous diahemofiltration in infants and children. Pediatr Nephrol 1994;8:96-102.
5. Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 1987;111:324-8.
6. St John RC, Dorinsky PM. Immunologic therapy for ARDS, septic shock, and multiple-organ failure. Chest 1993;103:932-43.
7. Parry MF, Neu HC. Pharmacokinetics of ticarcillin in patients with abnormal renal function. J Infect Dis 1976;133:46-9.
8. Bawdon RE, Leveno KL, Cunningham FG, Nobles B, Nelson S. Intrapartum pharmacokinetics of ticarcillin and clavulanic acid in serum as determined by high-pressure liquid chromatography. Adv Ther 1984;1:419-26.
9. Dupuis RE, Matzke GR, Maddux FW, O'Neil MG. Vancomycin disposition during continuous arteriovenous hemofiltration. Clin Pharm 1989;8:371-4.
10. Golper TA. Drug removal during continuous hemofiltration or hemodialysis. In: Sieberth HG, Mann H, Stummvoll HK, eds. Pharmacokinetics. Basel: Karger, 1991:110-16.
11. Armstrong DK, Hidalgo HA, Eldadah M. Vancomycin and tobramycin clearance in an infant during continuous hemofiltration. Ann Pharmacother 1993;27:224-7.
12. Mueller BA, Scarim SK, Macias WL. Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration. Am J Kidney Dis 1993;21:172-9.
13. Boulieu R, Bastien O, Bleyzac N. Pharmacokinetics of glanciclovir in heart transplant patients undergoing continuous venovenous hemodialysis. Ther Drug Monit 1993;15:105-7.
14. Reetze-Bonorden P, Böhler J, Keller E. Drug dosage in patients during continuous renal replacement therapy. Clin Pharmacokinet 1993;24:362-79.
15. deGroot R, Hack BD, Weber A, Chaffin D, Ramsey B, Smith AL. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study. Clin Pharmacol Ther 1990;47:73-8.
16. Bennett S, Wise R, Weston D, Dent J. Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid. Antimicrob Agents Chemother 1983;23:831-4.
17. Scully BE, Chin N, Neu HC. Pharmacology of ticarcillin combined with clavulanic acid in humans. Am J Med 1985;79(suppl 5B):39-43.
18. Hardin TC, Butler SC, Ross S, Wakeford JH, Jorgensen JH. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effect of differential pharmacokinetics on serum bactericidal activity. Pharmacotherapy 1994;14:147-52.